New England Journal of Medicine, 384 (11), 9891002.
While GHK-Cu has a strong safety record and compelling mechanistic data, most of the clinical evidence remains in the early-to-moderate phase
Semaglutide: Detailed Mechanism of Action Semaglutide is a medication used primarily to treat Type 2 diabetes and aid in weight loss
Animal research has examined its potential to accelerate tissue repair, promote angiogenesis (new blood vessel formation), reduce localized inflammation, support gut and ulcer healing, and enhance tendon and ligament recovery
Thirty four years since the discovery of gastrointestinal melatonin
4, the three most frequently reported SOC categories were "Gastrointestinal disorders," "General disorders and administration site conditions," and "Investigations." Notably, while "Injury, poisoning, and procedural complications" and "Nervous system disorders" demonstrated higher reporting frequencies compared to other SOCs, these associations did not reach statistical significance in our analysis, suggesting potential reporting bias or confounding factors that warrant further investigation